NCT00050843已完成3 期
A Study to Access the Safety/Efficacy of Thalidomide in the Treatment of Anemia in Patients With Myelodysplastic Syndromes
适应症
相关药物
试验速览
- 阶段
- 3 期
- 状态
- 已完成
- 入组人数
- 220
- 试验地点
- 38
研究概览
简要总结
The primary objective of the study is to determine the efficacy of thalidomide for the treatment of anemia in patients with myelodysplastic syndromes (MDS).
研究设计
- 研究类型
- Interventional
- 分配方式
- Randomized
- 干预模型
- Parallel
- 主要目的
- Treatment
- 盲法
- Double
入排标准
- 年龄范围
- 18 Years 至 80 Years（Adult, Older Adult）
- 性别
- All
- 接受健康志愿者
- 否
入选标准
- •Eligible patients must have a diagnosis of myelodysplastic syndrome
- •Life expectancy of at least 6 months.
- •Patients must be able to adhere to the study visit schedule and other protocol requirements.
- •Patients must understand and voluntarily sign an informed consent document.
- •Women of childbearing potential (WCBP) must agree to practice abstinence or to use TWO methods of contraception beginning 4 weeks prior to the start of study medication and throughout the course of treatment.
- •Males must use barrier contraception when engaging in reproductive sexual activity with women of childbearing potential.
排除标准
- 未提供
研究者
研究点 (38)
Loading locations...
相似试验
Unknown
4 期
A Study of Thalidomide in the Treatment of Refractory Uremic PruritusThalidomideHaemodialysisUremic PruritusNCT05525234RenJi Hospital40
Unknown
2 期
The Effective and Safety of Thalidomide in TIThalassemiaNCT03184844Xiao-Lin Yin100
已完成
3 期
Thalidomide for Multiple MyelomaMultiple MyelomaNCT00038233M.D. Anderson Cancer Center27
终止
2 期
Safety and Efficacy Study of Thalomid in Patients With Chronic PancreatitisChronic PancreatitisNCT00469703Winthrop University Hospital10
已完成
2 期
The Effects of Thalidomide on Symptom ClustersAdvanced CancersNCT00379353M.D. Anderson Cancer Center32